Vesync IPO Trading - Priced at Top-End but Still Reasonable
Vesync (2148 HK) raised US$200m in its Hong Kong IPO, priced at the top-end of its price range. The company sells small home appliances mainly...
709 Views
HSCI Index Rebalance and Stock Connect: Early Look at Potential Changes
While the HSCI does not have assets benchmarked to it, the index review is closely watched since the index forms the basis of stocks that are a...
405 Views
A Different Angle - RemeGen Vs Akeso (Insights on Valuation)
In this article, by comparing RemeGen and Akeso's pipelines from different aspects to provide referable and helpful insights about the valuation...
341 Views
Simcere (先声制药) IPO Trading: Mind the Sentiment Changes
We are of the view that the deal will not perform well compared to previous hot biotech deals as it is fairly valued and the sentiment is weak for...
433 Views
ECM Weekly (18 October 2020) - Lufax, Simcere, KWG Living, GDS, Jacobio
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. This week...
365 Views